Will upgrade to state-of-the-art technology

A quick look at all the leading modalities in the market

Will be part of its Image-Guided Therapy Business Group

Helps quantify and quickly diagnose conditions

Would create a group with at least a 75 percent share of physician services

The nuclear medicine world is preparing for the introduction of Ga-68 tracers

Light-sheet microscope can scan excised breast tissue for cancer cells in 30 minutes

Shifting from reactive to proactive to reduce breaches

Imaging with glucose using 7T MR scanner

But what about cost-effectiveness?

What to look for when your facility is investing in new systems

A call to reduce variability in imaging methods used at clinical practices

Expanding a key manufacturing and R&D facility

Company plans to establish new neurology portfolio

Could have implications for stroke victims, Alzheimer's

Says GTC replacement market in 'significant' decline

Automated beds becoming a popular choice

Giving providers more time to adjust to new requirements

Company aims to attract more U.S. customers

Planned launch in second half of 2017

Henry Ford is installing the MRIdian Linac from ViewRay

Mute sequences use software to cut sound by 99 percent

How the son of a notary discovered one of mankind's most troubling neurological diseases

DoD to invest in over 100 RadPRO1 SOLTUS 100M systems

Workload and time constraints stand in the way

Focusing on one of four ways in which artificial intelligence is disrupting medicine

Addressing challenges of reprocessing and reducing HAIs at MD&M East in NYC

'It seems cancer and heart disease coexist in a race to kill cancer survivors'

May reduce unnecessary biopsies

How PET and SPECT are reinventing the way we evaluate and image the brain

Can [F-18] MK-6240 stage neuro-degenerative disease and assess treatment?

Prescient Imaging aims to bring molecular imaging to the patient

Research from Australia presented at SNMMI

Swedish researchers take lifesaving cardiac devices to the sky

Unique market forces influence the utilization of different tracers

Showcasing lower doses, faster scan times and higher sensitivity

Scans up to 30 percent faster than previous generations

Assessing amyloid pathology and neuronal injury in a single session

Findings may have practice-changing implications

Ninety percent of the clot can be dissolved in four hours